HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

OMB CLEARS ADS FOR FDA CONSOLIDATED CAMPUS SITE

This article was originally published in The Rose Sheet

Executive Summary

OMB CLEARS ADS FOR FDA CONSOLIDATED CAMPUS SITE after working out some financing details. Advertising in the March 21 Washington Post for possible sites for FDA's centers for drugs, biologics and devices and the commissioner's office is the next step towards FDA consolidation, following the Office of Management and Budget's March 15 approval of an $888 mil., two-campus plan. The ad requests that written replies be returned to the General Services Administration by April 15.
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

RS000257

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel